Navigation Links
Aeon Bioscience Continues Development of Drug Eluting Stents
Date:10/10/2007

BIRMINGHAM, Ala., Oct. 10 /PRNewswire-USNewswire/ -- Aeon Bioscience, Inc. today announced the recent acquisition of one of its key collaborators, Brookwood Pharmaceuticals, Inc. by SurModics, Inc., a major development in its quest to develop improvements in drug-eluting stent technology for the treatment of cardiovascular disease.

Aeon Bioscience was formed as a collaborative enterprise between Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures, LLC. Subsequent to announcing the collaboration on May 7, 2007, Brookwood was acquired on August 1, 2007 by SurModics, Inc., a leading provider of surface modification and drug delivery technologies to the healthcare industry. As a result of this acquisition, Aeon expects to benefit from SurModics' experience in developing drug delivery technologies for drug eluting stents.

Christopher E. Banas, Principal of Targeted Technology Ventures and CEO of Aeon Bioscience, said "The combined strengths of Brookwood and TTV have supplied Aeon with superior experience and talent in the use of biodegradable materials, drug delivery, vascular stent engineering, clinical testing, and the regulatory process. The addition of the SurModics team facilitates our ability to advance our technology to an even higher level, and at an accelerated pace, as we work to achieve our objective of developing a solution to the safety issues currently experienced with drug eluting stents." Dr. Paul Castella, Principal of TTV and co-founder of Aeon agrees, "We have an exceptional operating team, a renowned advisory board of international leaders in the field, and now a prominent set of added capabilities."

Dr. Arthur J. Tipton, Ph.D., President of Brookwood Pharmaceuticals, added "We remain excited about the opportunity presented by the Aeon technology. This collaboration will substantially benefit from the vast experience and expertise that the SurModics organization has accumulated in the cardiovascular market." '/>"/>

SOURCE Aeon Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. OxyContin Abuse Continues To Rise
2. Alzheimer’s Continues to Ris
3. Uttar Pradesh Encephalitis toll continues to rise - Over 600 dead
4. Human Brain Continues To Evolve And Grow
5. War Against Cancer Continues
6. Botswana Continues Its Fight Against AIDS
7. US Continues Its War On Diabetes
8. Polio Continues To Haunt India
9. Reservation boycott by Medical student fraternity continues in Bangalore
10. Patients Left Helpless As Mumbai Doctors Strike Continues
11. Health Services Came To A Halt As Mumbai Doctors Strike Continues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Pawtucket, Rhode Island (PRWEB) July 30, 2014 ... being a Presenting Sponsor at the Free to Breathe ... Rhode Island. Free to Breathe is a non-profit organization ... from this event will help fund lung cancer research, ... to help navigate their disease and treatment options. , ...
(Date:7/30/2014)... July 30, 2014 Today, Gen. Arthur ... Coalitions of America (CADCA) , the nation’s leading substance ... to the New York Times Editorial Board’s ... July 27th. , “CADCA is disappointed in the ... call for national marijuana legalization. The move is shortsighted ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The global digital ... 2013 and is expected to grow at a CAGR of ... The demand for digital pathology is growing and is expected ... The use of scanners and image analysis software enable pathologists ... for patients. , In 2013, the North American market was ...
(Date:7/30/2014)... (PHILADELPHIA) Up to 20 percent of Parkinson,s ... a common but largely unrecognized challenge: the occurrence ... gambling, sexual behavior, eating, or spending. Yet the ... limit or complicate treatment options. A team of ... the University of Pennsylvania and the Parkinson,s Disease ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Effective ... is now accepting Highmark Blue Cross Blue Shield ... licensed dietetic nutritionist, Nourish Nutrition and Health opened ... downtown Pittsburgh, in Wexford. , The basis ... Health revolve around informing clients on the simplicity ...
Breaking Medicine News(10 mins):Health News:Rhode Island Medical Imaging Announces Partnership with Free to Breathe 2Health News:Rhode Island Medical Imaging Announces Partnership with Free to Breathe 3Health News:CADCA Responds to New York Times Editorial Board's Call for Marijuana Legalization 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Penn researchers: Naltrexone may diminish impulse control disorders in Parkinson's disease patients 2Health News:Nourish Nutrition and Health Now Accepting Highmark Insurance 2
... Dec. 13 (HealthDay News) -- In the aftermath of a ... the U.S. National Transportation Safety Board is recommending a nationwide ... devices, except in emergencies. According to media reports, the ... fatal pileup that occurred last year in Gray Summit, Mo. ...
... 14, 2011Caffeine is regarded by some as being a potent ... exercise performance. A range of expert opinions capture the scope ... in Journal of Caffeine Research , a quarterly peer-reviewed ... available online at www.liebertpub.com/jcr . Led by ...
... WASHINGTON -- A new Institute of Medicine report specifies ... Administration should require before allowing tobacco companies to sell ... of reducing the health risks of tobacco use. ... of a comprehensive strategy to lower tobacco-related death and ...
... an animal model is a difficult task, but Thomas ... Reporting in the Proceedings of the ... immunologists found that a specialized "human immune system" mouse model ... tick-borne infection known as relapsing fever, caused by the bacteria ...
... of its ongoing efforts to ensure safe, effective and ... joined the ABIM Foundation and eight other medical specialty ... choices by physicians and patients to improve health outcomes, ... dollars. The ACR will develop a list ...
... German . Compared to Neanderthals, modern humans have ... lobes and olfactory bulbs also suggest a combined use of ... of brain size is intimately linked to the evolution of ... independently evolved brains of roughly the same size but with ...
Cached Medicine News:Health News:U.S. Safety Board Urges Nationwide Ban on Drivers' Use of Cellphones 2Health News:New report identifies research needed on 'modified risk' tobacco products 2Health News:New report identifies research needed on 'modified risk' tobacco products 3Health News:Jefferson researchers mirror human response to bacterial infection and resolution in mice 2Health News:ACR in Choosing Wisely campaign to promote wise use of resources among physicians and patients 2Health News:Follow your nose 2
(Date:7/30/2014)... 30, 2014 Silicon Valley Bank, the bank ... today that examines the merger, acquisition and IPO ... According to the annual report based on 2013 data, ... since SVB started tracking the data in 2005. ... on solid healthcare M&A activity over the last few ...
(Date:7/30/2014)... and SAN DIEGO , July 30, ... ARNA ) announced today that an article based on ... lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and ... recently published in the online issue of Obesity , ... objective of these analyses was to identify whether there is ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... of new products for oncology supportive care, announced that ... has been featured in an article on OncLive.com titled, ... Head and Neck Cancers."  Dr. Steve Sonis , ... the growing demand seen in the oncology community for ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... 2012  A new nationwide survey finds that on ... questions from customers about vitamins and supplements as ... prescription medications.  The study also reveals pharmacists, top ... topics customers do ask about. (Photo: ...
... 2012 Marking a major milestone for the ... developer of oral drug delivery systems, announced today that it ... Patent Office. The patent covers an important part of the ... peptides. Oramed,s portfolio now consists of one issued patent and ...
Cached Medicine Technology:Top OTC Secrets From Your Pharmacist 2Top OTC Secrets From Your Pharmacist 3Top OTC Secrets From Your Pharmacist 4Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 2
Straight shafts with 1 x 2 teeth. Serrated handle with polished finish. Delicate teeth....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: